Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Adds TSQ Quantum Tools to BRIMS Program as Goals Move Downstream

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific said today it has expanded its Biomarker Research Initiative in Mass Spectrometry program to include new technology and programs that involve clinical validation and clinical application assays.
 
The BRIMS program, begun in 2004 with Massachusetts General Hospital, initially focused on discovering protein biomarkers, particularly those related to cardiovascular disease. It was intended to use Thermo’s LTQ FT and LTQ Orbitrap and other tools with Mass General’s bank of plasma samples.
 
BRIMS will now use Thermo’s TSQ Quantum triple-quadrupole platform and its TurboFlow sample-prep technology to develop assays for peptides and protein-biomarker quantitation.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.